Deleted Tweets From , -D.C.
's accounts: US_FDA
Tracking Since: October 16, 2019
This marks an important step in FDA’s response to the #COVID19 pandemic because it is the first SARS-CoV-2 diagnostic test that will be permitted to be marketed beyond the public health emergency.
Federal judge enters permanent injunction against Confidence USA, Inc. to cease manufacturing, holding or distributing adulterated dietary supplements that were prepared, packed, or held in violation of current good manufacturing practice regulations. https://t.co/KdqtmPslNZ
These violations are especially concerning during the ongoing pandemic, when consumers are even more susceptible to depression and mental health issues. FDA is committed to taking action to protect the public from unlawful dietary supplements.
Today, FDA announced warning letters to 10 companies for illegally selling dietary supplements that claim to cure, treat, mitigate, or prevent depression and other mental health disorders, in violation of the Federal Food, Drug, and Cosmetic Act. https://t.co/DjJvSp1aQO https://t.co/MQGvoFYGUd
RT @FDAfood: The @US_FDA helps to ensure the safety of baby foods sold or manufactured in the United States. See our response to… https://t.co/plT06OiA1W
RT @FDA_Drug_Info: Today, our Office of Generic Drugs (OGD) released their 2020 Annual Report which outlines how their strategic & pro… https://t.co/VN4IBw6jOO
Generic drugs can have a real impact for American patients - our generic drug program is stronger than ever, even during a time of unprecedented global health challenges. #FDAVoices https://t.co/AiOMWe9aoJ QT @FDA_Drug_Info: FDA released the 2020 Drug Trials Snapshots Summary Report highlighting last year’s 53 novel drug approvals by illu… https://t.co/dV4T7vomlu)
RT @DrWoodcockFDA: The ACTP resource is similar to the clinical trials website, which helps people locate clinical trials in a disease… https://t.co/UO6dWV7vJi
RT @US_FDA: Now more than ever...no double-dipping for the #SuperBowl. https://t.co/ycWZ3y5Fpz
Now more than ever...no double-dipping for the #SuperBowl. https://t.co/ycWZ3y5Fpz
RT @US_FDA: Join FDA Commissioner @SteveFDA and Deputy Commissioner for Medical and Scientific Affairs @AnandShahFDA for their… https://t.co/mkVD3PnK50
In our latest #FDAVoices find out about FDA’s new collaboration with @NIST to increase U.S. medical supply chain resilience and advance domestic manufacturing of pharmaceuticals, biopharmaceuticals, and medical devices. https://t.co/FdXJptV4W4
https://t.co/LKWI4T30Gu QT @FDA_Drug_Info: Did you know up to 80% of the sun’s rays can get through the clouds? 🌥️ Protect your skin even on cloudy winter da… https://t.co/cz2tQXJYZm)
. https://t.co/fFFuSEeYnn QT @US_FDA: It’s National Influenza Vaccination Week! This Wednesday we’re partnering with @CDCFlu to spread the word that flu… https://t.co/Wyhqoh8vfZ)
RT @FDADeviceInfo: Join @HHS and @US_FDA in developing technical innovations to help fight #COVID19! https://t.co/1ICbRJ5TK6
The #COVID19 At-Anywhere Diagnostics Design-a-thon brings together industry and all sectors to build digital solutions for data capture, harmonization, and reporting from diagnostic tests. https://t.co/6HTUJK7RMp
FDA Honorees @DrAbernethyFDA Principal Deputy Commissioner and Acting Chief Information Officer Beau Brooks Branch Chief, Internet/Intranet Sharon Campbell Associate Deputy Chief Information Officer & Director, Center for Tobacco Products Vid Desai Chief Technology Officer
For driving change and advancement in the federal health arena, FedHealthIT100 honors the following FDA staff. Congratulations and thank you for your fierce determination and dedication to drive innovation. https://t.co/e5VPKBz9GP https://t.co/gSWmYbmCFI
FDA Honorees @DrAbernethyFDA Principal Deputy Commissioner and Acting Chief Information Officer Beau Brooks Branch Chief, Internet/Intranet Sharon Campbell Associate Deputy Chief Information Officer & Director, Center for Tobacco Products Vid Desai Chief Technology Officer